A
ISSUER//CIK 0000861838
Aceragen, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K303.9 KBAceragen, Inc.Aug 16, 4:07 PM ET·0001104659-23-092550
- SC 13D/A132.2 KBAceragen, Inc.Aug 3, 4:59 PM ET·0001193125-23-202969
- 8-K197.5 KBAceragen, Inc.Jul 21, 4:05 PM ET·0001104659-23-083038
- SC 13D/A115.3 KBAceragen, Inc.Jul 17, 7:30 AM ET·0001193125-23-187666
- 8-K716.2 KBAceragen, Inc.Jul 11, 5:06 PM ET·0001104659-23-080018
- 10-Q7.7 MBAceragen, Inc.Jun 29, 4:30 PM ET·0001558370-23-011603
- 8-K243.7 KBAceragen, Inc.May 30, 4:30 PM ET·0001104659-23-066071
- 8-K213.3 KBAceragen, Inc.May 4, 8:52 AM ET·0001104659-23-055819
- 10-K13.1 MBAceragen, Inc.Apr 13, 4:31 PM ET·0001558370-23-005875
- SC 13D/A106.9 KBAceragen, Inc.Apr 10, 4:40 PM ET·0001193125-23-096589
Insiders
10- 14159, L.P.Director
- 667, L.P.Director
- Arbeit Robert D.VP Clinical Development
- Arcudi III Louis JChief Financial Officer
- BAKER BROS. ADVISORS LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
- BRENNER LOUIS MDChief Medical Officer
- Baker Biotech Capital (GP), LLC10% Owner
- Baker Bros. Advisors (GP) LLCDirector
Tickers
No tickers on record
Addresses
business
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
mailing
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
Former Names
- IDERA PHARMACEUTICALS, INC.2023-01-13
- HYBRIDON INC2005-09-02